Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: SVY, ECO, SCZ, DEI

Expanding Access in Low-/Middle-Income Countries to Drive Rising Global Healthcare Spending


Population growth, especially among older cohorts, to underlie increases

CLEVELAND, Sept. 23, 2022 /PRNewswire/ -- Global healthcare expenditures are projected to rise 3.4% annually in real terms through 2026, according to Global Healthcare, a report recently released by Freedonia Focus Reports. Spending will be driven by increasing access to myriad healthcare services in low- and middle-income countries and population growth, particularly in the cohort 50 years of age and older. Through 2026, North America is projected spend the most of any region on healthcare products and services. While North America represented only 6% of the global population in 2021, the region accounted for 38% of global healthcare expenditures due to intensive use of healthcare resources in the US, where healthcare represented 20% of GDP in 2021.

Low-income countries are expected to post the strongest growth in healthcare spending through 2026. Health expenditures in the Asia/Pacific region, for example, are forecast to increase 5.6% per year, while gains in the Africa/Mideast region are projected to grow 5.0% per annum. Rising incomes in many of these countries will support advances in healthcare expenditures. As of 2021, per capita healthcare expenditures in these regions were substantially lower than in the US or Western Europe. Rapid growth in spending will be in part a result of the low initial base.

Further growth in healthcare spending will be limited by shortages of medical personnel in many countries. While middle- and low-income countries will continue to suffer from the most extreme shortages, high-income countries are also projected to experience growing shortages of doctors and nurses through the forecast period. The intensifying shortage of medical staff in many high-income countries is in large part the result of the aging population, which leads to the need for more staffing. Additionally, the stress of the COVID-19 pandemic on medical personnel prompted many to retire or otherwise leave the profession.

These and other key insights are featured in Global Healthcare. This report forecasts to 2022 and 2026 the following measures related to global healthcare:

Healthcare expenditures are measured in real (inflation-adjusted) US dollars.

World regions include North America, Western Europe, Asia/Pacific, and all other regions.

In addition, for the three main regions, total and per capita healthcare expenditures are forecast for the largest economies within that region.

To illustrate historical trends, global, regional, and country expenditures are provided for 2011, 2016, and 2021.

More information about the report is available at:
https://www.freedoniafocusreports.com/Global-Healthcare-FW40017/?progid=91541 

About Freedonia Focus Reports
Each month, The Freedonia Group ? a division of MarketResearch.com ? publishes over 20 new or updated Freedonia Focus Reports, providing fresh, unbiased analysis on a wide variety of markets and industries. Published in 20-30 pages, Focus Report coverage ranges from raw materials to finished manufactured goods and related services such as freight and construction. Additional Healthcare & Biotechnology reports can be purchased at Freedonia Focus Reports or MarketResearch.com.

Analysis is intended to guide the busy reader through pertinent topics in rapid succession, including:

Press Contact:
Corinne Gangloff
+1 440.842.2400
cgangloff@freedoniagroup.com

SOURCE The Freedonia Group


These press releases may also interest you

at 06:35
Sage Therapeutics, Inc. and Biogen Inc. announced the completion of the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for zuranolone in the treatment of major depressive disorder (MDD) and...

at 06:35
Karuna Therapeutics, Inc. , a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced the appointment of Bill Meury as president...

at 06:35
The "Growth Opportunities in Onco-Immunotherapy, Genetic Therapy, Synthetic Biology, Microbiome Therapeutics" report has been added to ResearchAndMarkets.com's offering. This edition of the Life Science, Health & Wellness Technology Opportunity...

at 06:30
The increasing trend of outsourcing in several industries related to healthcare domain, such as life sciences, biotech, and pharmaceuticals, is boosting growth within the...

at 06:30
Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, and Hummingbird...

at 06:15
The "Biosimilar Therapeutic Peptides Global Market Report 2022: By Route, By Application, By Type" report has been added to  ResearchAndMarkets.com's offering. The global biosimilar therapeutic peptides market is expected to grow from $0.93 billion...



News published on 23 september 2022 at 10:17 and distributed by: